CN102775401A - 一种美洛昔康的合成方法 - Google Patents
一种美洛昔康的合成方法 Download PDFInfo
- Publication number
- CN102775401A CN102775401A CN2012102892377A CN201210289237A CN102775401A CN 102775401 A CN102775401 A CN 102775401A CN 2012102892377 A CN2012102892377 A CN 2012102892377A CN 201210289237 A CN201210289237 A CN 201210289237A CN 102775401 A CN102775401 A CN 102775401A
- Authority
- CN
- China
- Prior art keywords
- reaction
- add
- meloxicam
- bullion
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CN(C(C1OC1O*)=C(c1ccccc11)O)S1OC Chemical compound CN(C(C1OC1O*)=C(c1ccccc11)O)S1OC 0.000 description 1
- GUABFMPMKJGSBQ-UHFFFAOYSA-N Cc1cnc(N)[s]1 Chemical compound Cc1cnc(N)[s]1 GUABFMPMKJGSBQ-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210289237.7A CN102775401B (zh) | 2012-08-15 | 2012-08-15 | 一种美洛昔康的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210289237.7A CN102775401B (zh) | 2012-08-15 | 2012-08-15 | 一种美洛昔康的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102775401A true CN102775401A (zh) | 2012-11-14 |
CN102775401B CN102775401B (zh) | 2015-01-07 |
Family
ID=47120532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210289237.7A Active CN102775401B (zh) | 2012-08-15 | 2012-08-15 | 一种美洛昔康的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102775401B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106896162A (zh) * | 2015-12-17 | 2017-06-27 | 瑞普(天津)生物药业有限公司 | 一种检测美洛昔康片中杂质的hplc方法 |
WO2020259675A1 (zh) | 2019-06-28 | 2020-12-30 | 上海盛迪医药有限公司 | 神经激肽-1拮抗剂 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233299A (en) * | 1977-12-16 | 1980-11-11 | Boehringer Ingelheim Gmbh | 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxides and salts thereof |
CN101891737A (zh) * | 2009-05-22 | 2010-11-24 | 山东方明药业股份有限公司 | 一种Lewis酸催化氨解合成美洛昔康的方法 |
-
2012
- 2012-08-15 CN CN201210289237.7A patent/CN102775401B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233299A (en) * | 1977-12-16 | 1980-11-11 | Boehringer Ingelheim Gmbh | 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxides and salts thereof |
CN101891737A (zh) * | 2009-05-22 | 2010-11-24 | 山东方明药业股份有限公司 | 一种Lewis酸催化氨解合成美洛昔康的方法 |
Non-Patent Citations (2)
Title |
---|
TIBOR MEZEI,ET AL.: ""Manufacture of High-Purity Meloxicam via Its Novel Potassium Salt Monohydrate"", 《ORGANIC PROCESS RESEARCH & DEVELOPMENT 》 * |
刘旭桃,等.: ""美洛昔康合成工艺改进"", 《中南药学》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106896162A (zh) * | 2015-12-17 | 2017-06-27 | 瑞普(天津)生物药业有限公司 | 一种检测美洛昔康片中杂质的hplc方法 |
CN106896162B (zh) * | 2015-12-17 | 2019-10-18 | 瑞普(天津)生物药业有限公司 | 一种检测美洛昔康片中杂质的hplc方法 |
WO2020259675A1 (zh) | 2019-06-28 | 2020-12-30 | 上海盛迪医药有限公司 | 神经激肽-1拮抗剂 |
Also Published As
Publication number | Publication date |
---|---|
CN102775401B (zh) | 2015-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2585221T3 (es) | Un proceso para la preparación de 6-(7-((1-aminociclopropil)metoxi)-6-metoxiquinolin-4-iloxi)-n-metil-1-naftamida y productos intermedios sintéticos de la misma | |
CN103387541A (zh) | 一种取代吡唑醚类化合物的制备方法 | |
CN104860938A (zh) | 关环法合成多氮杂环噻二唑-5-甲脒类化合物 | |
CN102746231A (zh) | 塞来昔布制备工艺 | |
CN104151297A (zh) | 4-[5-(吡啶-4-基)-1h-[1,2,4]三唑-3-基]吡啶-2-甲腈的制备方法 | |
CN105566237B (zh) | 一种治疗痛风的三唑巯乙酸类化合物的制备方法 | |
CN102850325A (zh) | 一种达比加群酯关键中间体的制备方法 | |
Tang et al. | Synthesis of novel β-amino ketones containing ap-aminobenzoic acid moiety and evaluation of their antidiabetic activities | |
CN111423394A (zh) | 1,3,4-恶二唑杂环化合物的合成方法 | |
CN102775401B (zh) | 一种美洛昔康的合成方法 | |
WO2015039387A1 (zh) | 4,6-二卤代嘧啶-5-乙醛的制备方法 | |
TW201918475A (zh) | 一種亞托敏(Azoxystrobin)的製備方法 | |
Shanmugam et al. | Synthesis, characterization and biological studies of some novel 3-fluorosalicylaldehyde based amine derivatives | |
KR100720220B1 (ko) | 치환 아닐린 화합물의 제조방법 | |
CN106631885A (zh) | 一种制备4‑甲醛肟基苯甲酸酯类衍生物的方法 | |
CN101723897A (zh) | 伊伐布雷定的合成方法 | |
CN103102306A (zh) | 一种塞来昔布的制备方法 | |
JP6884857B2 (ja) | フェニルアラニン類化合物の製造方法 | |
Sun et al. | Synthesis, crystal structure and antifungal activities of new quinoline derivatives | |
CN102250083B (zh) | 一种齐拉西酮制备方法 | |
CN103396373A (zh) | 地拉罗司的制备方法及其中间体化合物 | |
CN107686465B (zh) | 地拉考昔的制备方法 | |
CN110698426B (zh) | 叔丁醇钾高效催化制备1,3-苯并噻唑衍生物的方法 | |
CN102516215A (zh) | 含饱和环己烷结构的c-葡萄糖苷的制备方法 | |
CN101260079B (zh) | 一种7,8-二氢喹啉-2,5(1h,6h)-二酮类衍生物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 266109 Qingdao Road, Chengyang District, Shandong, No. 700 the Great Wall Applicant after: Qingdao Agricultural University Applicant after: QINGDAO VLAND BIOLOGICAL CO., LTD. Applicant after: Heze Puen Pharmaceutical Co., Ltd. Address before: 266109 Qingdao Road, Chengyang District, Shandong, No. 700 the Great Wall Applicant before: Qingdao Agricultural University Applicant before: Qingdao KDN Pharmaceutical Co., Ltd. Applicant before: Heze Puen Pharmaceutical Co., Ltd. |
|
CB02 | Change of applicant information | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |